Health Problems

Pembrolizumab in metastatic NSCLC: Now added benefit for subpopulations

In early July, the German Institute for Quality and Efficiency in Health Care (IQWiG) conducted two early benefit assessments to investigate whether certain drug combinations with pembrolizumab have advantages in comparison with the respective appropriate comparator therapy for patients with metastatic squamous or non-squamous non-small cell lung cancer (NSCLC). Due to a contradictory presentation of […]

Health News

Mechanical, oral antibiotic bowel prep yields no benefit for colectomy

(HealthDay)—Mechanical and oral antibiotic bowel preparation (MOABP) does not reduce surgical site infections (SSIs) or the overall morbidity of colon surgery versus no bowel preparation (NBP), according to a study published online Aug. 8 in The Lancet. Laura Koskenvuo, M.D., from University of Helsinki, and colleagues randomly assigned (1:1) 396 patients undergoing colon resection to […]

Health News

Putting health data to work to benefit a nation’s population

Women In Health ITResource Center Stay Informed Susbscribe today to receive our FREE monthly e-newsletter Have valuable and interesting information to share? contribute today! Featured Contributors Laura Lovett is an associate editor at MobiHealthNews where she covers the intersection of healthcare and technology. She is also a contributing editor to Women in Healthcare IT at […]

Health News

No Clear Benefit for Rivaroxaban After Hospital Discharge

WEDNESDAY, Sept. 19, 2018 — Rivaroxaban does not lower risk of symptomatic venous thromboembolism and related death in medical patients after hospital discharge, compared to placebo, according to a study published in the Sept. 20 issue of the New England Journal of Medicine. Alex C. Spyropoulos, M.D., from Northwell Health at Lenox Hill Hospital in […]